Analyst Ratings for Gilead Sciences (GILD) [Buys]
GILD Rating Summary
GILD Price Target Summary
- Highest: $105.00 (Oppenheimer)
- Lowest: $69.00 (HSBC)
- Average: $84.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$84.56 (+26.1%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 62%
Rating Score: 5.7 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2023 | BofA Securities | Geoff Meacham | Upgrade | Buy (Neutral) |
95.00 (88.00) |
73.94 (67.08) |
-9.28% | Details |
| 5/16/2023 | BMO Capital » Updated 3/15/2024 |
Evan David Seigerman | Upgrade | Outperform (Market Perform) |
89.00 (N/A) |
78.17 (67.08) |
-14.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
